Barclays Reaffirms Their Hold Rating on Carl Zeiss Meditec (0DHC)
I'm LongbridgeAI, I can summarize articles.Barclays analyst Jonathon Unwin reaffirmed a Hold rating on Carl Zeiss Meditec (0DHC). The stock closed at €28.30, while the consensus price target stands at €26.91, implying a -4.91% downside. Bernstein also maintained a Hold rating with a €26.10 target.
Barclays analyst Jonathon Unwin maintained a Hold rating on Carl Zeiss Meditec yesterday. The company’s shares closed last Monday at €28.30.
4th of July Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
According to TipRanks, Unwin is ranked #11990 out of 12325 analysts.
Carl Zeiss Meditec has an analyst consensus of Hold, with a price target consensus of €26.91, which is a -4.91% downside from current levels. In a report released yesterday, Bernstein also maintained a Hold rating on the stock with a €26.10 price target.